Remove 2005 Remove Packaging Remove Pharmaceuticals Remove Therapies
article thumbnail

Extraordinary General Meeting in Oncopeptides AB (publ) – Nov 03, 2020

The Pharma Data

Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases. Rein Piir, Head of Investor Relations at Oncopeptides, E-mail: rein.piir@oncopeptides.com. This information was submitted for publication at 8.00 CET on 3 November 2020. About Oncopeptides.

article thumbnail

Discovering an Antimalarial Drug in Mao’s China

Codon

However, the blandly clinical package of artemisinin and artesunate tablets reveals little about how the key compound was first discovered. It was only in 2005, after the emergence of widespread resistance of P. It was only in 2005, after the emergence of widespread resistance of P.

Drugs 129
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Unimpressed Learned Intermediaries Defeat Warning Causation

Drug & Device Law

The plaintiffs’ causation allegations foundered in Himes because the treating physician did not believe that the claimed risks of electroconvulsive therapy were all that big of a deal, and thus did not warn about it. Bayer HealthCare Pharmaceuticals, Inc. , Wyeth Pharmaceuticals , 526 F.3d Janssen Pharmaceuticals, Inc.

article thumbnail

Confident Learned Intermediaries Defeat Warning Causation

Drug & Device Law

Bayer HealthCare Pharmaceuticals, Inc. , Wyeth Pharmaceuticals , 526 F.3d Janssen Pharmaceuticals , 2018 WL 1977258, at *12 (Mag. Teva Pharmaceuticals USA, Inc. , Novartis Pharmaceuticals Corp. , Boehringer Ingelheim Pharmaceuticals, Inc. Janssen Pharmaceuticals, Inc. 3d 1223, 1233 (11th Cir.